The significance of the PI3K/AKT pathway and its potential as a therapeutic target for cancer treatment have been investigated in preclinical studies of several types of human cancer, including renal cancer, lung cancer, breast cancer, glioblastoma, neuroblastoma, and HCC. This evidence concerns the gene AKT1 and hepatocellular carcinoma.